A Pharmacokinetic Study to Evaluate the Effect of MAALOX on Raltegravir (MK-0518) in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-295)
Clinical trial NCT01930045 · COMPLETED
Trial details
- NCT number
- NCT01930045
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2013-12-10
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.